Iron Regulating Protein-2 (IRP-2) as a Diagnostic For Neurodegenerative Disease

Details for Australian Patent Application No. 2008202723 (hide)

Owner Loma Linda University Medical Center The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services

Inventors Kirsch, Wolff M.; Levine, Rodney L.; Anton, Lennart; Roualt, Tracey A.; Kang, Dae-Kyung; Kelln, Wayne J.

Agent Cullen & Co

Pub. Number AU-A-2008202723

Parent 2001284742

Filing date 20 June 2008

Wipo publication date 10 July 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

10 July 2008 Application Open to Public Inspection

  Published as AU-A-2008202723

10 July 2008 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008202724-Mounting structure of semiconductor optical element

2008202722-A Padlock